SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
20-May-24 5:03 PM View: | Enliven Therapeutics, Inc. (ELVN) | 16-May-24 | Private Sale Duplicate | 1,033,300 | $22.14 | $22,877,300.00 | (12%) 8.95M to 7.92M | |
24-Jul-23 4:40 PM View: | Turnstone Biologics Corp. (TSBX) | 20-Jul-23 | Conversion Duplicate | 2,682,600 | -- | -- | 100% 0 to 2.68M | |
24-Jul-23 4:40 PM View: | Turnstone Biologics Corp. (TSBX) | 20-Jul-23 | Purchase Duplicate | 416,666 | $12.00 | $4,999,990.00 | 16% 2.68M to 3.1M | |
19-May-23 4:12 PM View: | Enliven Therapeutics, Inc. (ELVN) | 17-May-23 | Option Exercise | 2,125 | $4.28 | $9,095.00 | < 1% 8.95M to 8.95M | |
15-May-23 6:06 PM View: | Verona Pharma Plc (VRNA) | 15-May-23 | Sale | 359,713 | $20.08 | $7,222,480.00 | (9%) 4.14M to 3.78M | |
15-May-23 6:06 PM View: | Verona Pharma Plc (VRNA) | 12-May-23 | Sale | 43,200 | $21.64 | $934,848.00 | (1%) 4.18M to 4.14M | |
15-May-23 6:06 PM View: | Verona Pharma Plc (VRNA) | 11-May-23 | Private Sale | 80,000 | $22.26 | $1,780,800.00 | (2%) 4.26M to 4.18M | |
27-Feb-23 9:53 PM View: | Enliven Therapeutics, Inc. (ELVN) | 23-Feb-23 | Grant Duplicate | 7,899,570 | -- | -- | 100% 0 to 7.9M | |
27-Dec-22 5:32 PM View: | Verona Pharma Plc (VRNA) | 23-Dec-22 | Sale | 2,170,370 | $22.84 | $49,576,600.00 | (6%) 36.26M to 34.09M | |
27-Dec-22 5:32 PM View: | Verona Pharma Plc (VRNA) | 22-Dec-22 | Private Sale | 3,969,500 | $21.77 | $86,424,200.00 | (10%) 40.23M to 36.26M | |
29-Oct-15 6:14 PM View: | Dimension Therapeutics, Inc. (DMTX) | 27-Oct-15 | Conversion | 5,197,700 | -- | -- | 100% 0 to 5.2M | |
29-Oct-15 6:14 PM View: | Dimension Therapeutics, Inc. (DMTX) | 27-Oct-15 | Purchase | 200,000 | $13.00 | $2,600,000.00 | 4% 5.2M to 5.4M |